참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 2-Aminooxazole | HCID 558521 | — |
| 반응물 | 2-Bromo-4-chloropyridine | HCID 2762836 | — |
| 시약 | Phenolate Sodium | HCID 4445035 | — |
| 촉매 | 1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine) | HCID 636044 | — |
| 촉매 | Bis(dibenzylideneacetone)palladium | HCID 9811564 | — |
| 용매 | 1,4-Dioxane | HCID 31275 | — |
| 생성물 | N-(4-chloro-2-pyridinyl)-1,3-oxazol-2-amine | HCID 130016260 | 0.5% |
반응 단계
Objective: Improve yield of the desired product starting from the bromoaryl compound. To a flask containing 2-bromo-4-chloropyridine (196 mg, 1.02 mmol), sodium phenolate (177 mg, 1.52 mmol), TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (11.63 mg, 0.01 mmol) and (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (17.64 mg, 0.03 mmol) (Xantphos), was added degassed dioxane (4 mL) and the mixture allowed to stir under nitrogen atmosphere for 5 min. To this solution was added oxazol-2-amine (94 mg, 1.12 mmol) and the reaction mixture was heated to 170 °C for 2 h under microwave irradiation. Methanol was added to the crude reaction mixture together with silica (2 g), the solvent was removed under reduced pressure and the remaining residue was placed in dry load tube prior to chromatography. The crude product was purified by flash silica chromatography, elution gradient 0 to 100% EtOAc in heptane. Pure fractions were evaporated to dryness to afford N-(4-chloropyridin-2-yl)oxazol-2-amine (1.000 mg, 0.503 %) as a beige solid. Conclusion: Trace amount of the desired product isolated.
출처 및 근거
| 출처 데이터셋 | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-16b6dbfada904ea1b6f495fddc318fb3 |
|---|
| 출처 메모 | 750 AstraZeneca ELN dataset |
|---|